Potential for malaria to be contained in high-risk populations, particularly children
In a major breakthrough for malaria treatment European researchers have shown that mice infected with the disease administered antibiotics developed immunity against re-infection.
Australian researchers have made exciting progress towards a malaria vaccine, and the past year has seen major research developments that raise real hope that malaria can even be eradicated.
Malaria is not only devastating to the individuals who suffer from it, but it also prevents many of the poorest countries around the world from emerging from poverty. A 2001 report by the Center for International Development found that countries with widespread malaria infection had income levels only one third that of similar countries without malaria - and that's adjusting for all other variables. So malaria is not just a health issue, it's a massive socio-political problem, the solving of which could benefit untold millions.
Diversity of human genes on the continent could hold key to new disease cures.
An ambitious new health project announced this week will seek to capitalise on Africa’s unique genetic diversity in a bid to further understanding of how genes interact with the environment in relation to diseases such as cancer, heart disease and malaria.
Australian-led group of researchers closes in on novel malaria treatment
Researchers from Australia’s Walter and Eliza Hall and Burnett Institutes, and the Imperial College London have completed a potentially ground breaking study examining the ability of heparin-like molecules to neutralise the
malaria virus before it reaches the red blood cells.
Vaccination by mosquito could become a new method of protecting people from diseases.
Vaccination by mosquito could become a new method of protecting people from diseases.
$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering.
$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering.
Researchers at the WEHI have identified a protein that could present an attractive drug target to prevent the parasite's spread through the blood.
Researchers at the WEHI have identified a protein that could present an attractive drug target to prevent the parasite's spread through the blood.
Australian and international researchers identify an enzyme that could prove an effective anti-malaria drug target.
Australian and international researchers identify an enzyme that could prove an effective anti-malaria drug target.
Only a small fraction of proteins that could act as vaccine against blood-stage malaria candidates have been thoroughly studied, say WEHI scientists.
Only a small fraction of proteins that could act as vaccine against blood-stage malaria candidates have been thoroughly studied, say WEHI scientists.
Seven US$100,000 grants awarded to Australian researchers to study infectious diseases.
Seven US$100,000 grants awarded to Australian researchers to study infectious diseases.
The Australian Museum Eureka Prizes showcase research done by researchers in the life sciences.
The Australian Museum Eureka Prizes showcase research done by researchers in the life sciences.
Genomes of two malaria parasite species sequenced
Genomes of two malaria parasite species sequenced
Toby Sargeant has used new statistical techniques to trace the evolutionary development of the Plasmodium species of parasites and the relationship between different clades.
Toby Sargeant has used new statistical techniques to trace the evolutionary development of the Plasmodium species of parasites and the relationship between different clades.
Alan Cowman’s group from WEHI may have found a weakness in the armour of the malaria parasite – by harnessing P. falciparum’s key defence strategy, they plan to turn it against itself.
Alan Cowman’s group from WEHI may have found a weakness in the armour of the malaria parasite – by harnessing P. falciparum’s key defence strategy, they plan to turn it against itself.
Professor Alan Cowman of the Walter and Eliza Hall Institute will deliver the Rubbo Oration at this year’s Australian Society of Microbiology (ASM) annual meeting, being held in Melbourne next week.
Professor Alan Cowman of the Walter and Eliza Hall Institute will deliver the Rubbo Oration at this year's Australian Society of Microbiology (ASM) annual meeting, being held in Melbourne next week.
